126 related articles for article (PubMed ID: 3611738)
41. Intermediate filaments as dynamic structures.
Klymkowsky MW
Cancer Metastasis Rev; 1996 Dec; 15(4):417-28. PubMed ID: 9034601
[No Abstract] [Full Text] [Related]
42. Anti-neurofilament monoclonal antibodies: reagents for the evaluation of human neoplasms.
Trojanowski JQ; Lee VM
Acta Neuropathol; 1983; 59(2):155-8. PubMed ID: 6682279
[TBL] [Abstract][Full Text] [Related]
43. [Nestin in the cells of the central nervous system].
Giliarov AV
Morfologiia; 2007; 131(1):85-90. PubMed ID: 17526272
[TBL] [Abstract][Full Text] [Related]
44. Intermediate filaments.
Hendrix MJ
Cancer Metastasis Rev; 1996 Dec; 15(4):413-6. PubMed ID: 9034600
[No Abstract] [Full Text] [Related]
45. Intermediate filaments: cell-type-specific markers in differentiation and pathology.
Osborn M; Weber K
Cell; 1982 Dec; 31(2 Pt 1):303-6. PubMed ID: 6891619
[No Abstract] [Full Text] [Related]
46. [The cytoskeleton of nerve cells during their differentiation].
Skibo GG; Berezovskaia OL
Neirofiziologiia; 1987; 19(4):558-67. PubMed ID: 3309686
[TBL] [Abstract][Full Text] [Related]
47. A review of intermediate filament biology and their use in pathologic diagnosis.
Nagle RB
Mol Biol Rep; 1994 Jan; 19(1):3-21. PubMed ID: 8170466
[No Abstract] [Full Text] [Related]
48. On the assembly mechanism of neurofilaments.
Tokutake S
Int J Biochem; 1990; 22(1):1-6. PubMed ID: 2184054
[TBL] [Abstract][Full Text] [Related]
49. Viscoelasticity of intermediate filament networks.
Janmey PA; Shah JV; Janssen KP; Schliwa M
Subcell Biochem; 1998; 31():381-97. PubMed ID: 9932499
[No Abstract] [Full Text] [Related]
50. Filaments of Pick's bodies contain altered cytoskeletal elements.
Perry G; Stewart D; Friedman R; Manetto V; Autilio-Gambetti L; Gambetti P
Am J Pathol; 1987 Jun; 127(3):559-68. PubMed ID: 3296772
[TBL] [Abstract][Full Text] [Related]
51. Intermediate filaments: structure, dynamics, function, and disease.
Fuchs E; Weber K
Annu Rev Biochem; 1994; 63():345-82. PubMed ID: 7979242
[No Abstract] [Full Text] [Related]
52. Intermediate filaments mediate cytoskeletal crosstalk.
Chang L; Goldman RD
Nat Rev Mol Cell Biol; 2004 Aug; 5(8):601-13. PubMed ID: 15366704
[TBL] [Abstract][Full Text] [Related]
53. Is polypeptide heterogeneity the key to neurofilament function?
Calvert R
Nature; 1982 Dec; 300(5893):580-1. PubMed ID: 6890630
[No Abstract] [Full Text] [Related]
54. Technical considerations in the immunohistochemical demonstration of intermediate filaments.
DeLellis RA; Kwan P
Am J Surg Pathol; 1988; 12 Suppl 1():17-23. PubMed ID: 2451441
[TBL] [Abstract][Full Text] [Related]
55. Cytoskeleton of cartilage cells.
Benjamin M; Archer CW; Ralphs JR
Microsc Res Tech; 1994 Aug; 28(5):372-7. PubMed ID: 7919524
[TBL] [Abstract][Full Text] [Related]
56. "IF-pathies": a broad spectrum of intermediate filament-associated diseases.
Omary MB
J Clin Invest; 2009 Jul; 119(7):1756-62. PubMed ID: 19587450
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic markers in human neurooncology. A progress report.
Rubinstein LJ
Ann N Y Acad Sci; 1988; 540():78-90. PubMed ID: 2462847
[TBL] [Abstract][Full Text] [Related]
58. Stress models for the study of intermediate filament function.
Lane EB; Pekny M
Methods Cell Biol; 2004; 78():229-64. PubMed ID: 15646621
[No Abstract] [Full Text] [Related]
59. Are intermediate filament proteins involved in gene expression?
Traub P
Ann N Y Acad Sci; 1985; 455():68-78. PubMed ID: 2867728
[No Abstract] [Full Text] [Related]
60. Intermediate filaments: dynamic processes regulating their assembly, motility, and interactions with other cytoskeletal systems.
Goldman RD; Chou YH; Prahlad V; Yoon M
FASEB J; 1999 Dec; 13 Suppl 2():S261-5. PubMed ID: 10619140
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
